-transparent.png){kind=logo}
A 20-month-old child was treated for acute nonlymphocytic leukemia (ANLL) with basophilic differentiation. His leukemic cells also had the cytogenetic abnormality of t(9,11)(p22,q23). Although immature blasts responded well to induction therapy with etoposide, the leukemic cells that were more differentiated toward basophils were quite refractory to the drug. However, complete remission was finally achieved with a conventional multidrug regimen.
Related Publications
M Kubota, and
Y Akiyama, and
Y Tabata, and
M Yoshigi, and
H Mikawa
July 1982,
Blood,
M Kubota, and
Y Akiyama, and
Y Tabata, and
M Yoshigi, and
H Mikawa
July 2013,
The Journal of dermatology,
M Kubota, and
Y Akiyama, and
Y Tabata, and
M Yoshigi, and
H Mikawa
April 2014,
International journal of surgical pathology,
M Kubota, and
Y Akiyama, and
Y Tabata, and
M Yoshigi, and
H Mikawa
February 1985,
Cancer genetics and cytogenetics,
M Kubota, and
Y Akiyama, and
Y Tabata, and
M Yoshigi, and
H Mikawa
February 1989,
Cancer genetics and cytogenetics,
M Kubota, and
Y Akiyama, and
Y Tabata, and
M Yoshigi, and
H Mikawa
January 2011,
Blood,
M Kubota, and
Y Akiyama, and
Y Tabata, and
M Yoshigi, and
H Mikawa
December 1991,
Sangre,
M Kubota, and
Y Akiyama, and
Y Tabata, and
M Yoshigi, and
H Mikawa
January 1986,
American journal of hematology,
M Kubota, and
Y Akiyama, and
Y Tabata, and
M Yoshigi, and
H Mikawa
September 1990,
Cancer genetics and cytogenetics,
M Kubota, and
Y Akiyama, and
Y Tabata, and
M Yoshigi, and
H Mikawa
July 1990,
Cancer genetics and cytogenetics,
